Recombinant multi-species MAPK13/SAPK4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAPK13/SAPK4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the mitogen-activated protein (MAP) kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The encoded protein is a p38 MAP kinase and is activated by proinflammatory cytokines and cellular stress. Substrates of the encoded protein include the transcription factor ATF2 and the microtubule dynamics regulator stathmin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012]
The Alternative Names of target: MAP kinase 13,MAPK 13,MAPK-13,MAPK13,Mapk13,Mitogen-activated protein kinase 13,Mitogen-activated protein kinase p38 delta (MAP kinase p38 delta),PRKM13,Prkm13,SAPK4,Serk4,Stress-activated protein kinase 4,p38delta

Target products collectionGo to MAPK13/SAPK4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10372-Ag-1/ GM-Tg-hg-IP10372-Ag-2 Human MAPK13/SAPK4 protein Human
GM-Tg-rg-IP10372-Ag-1/ GM-Tg-rg-IP10372-Ag-2 Rat MAPK13/SAPK4 protein Rat
GM-Tg-mg-IP10372-Ag-1/ GM-Tg-mg-IP10372-Ag-2 Mouse MAPK13/SAPK4 protein Mouse
GM-Tg-cynog-IP10372-Ag-1/ GM-Tg-cynog-IP10372-Ag-2 Cynomolgus/Rhesus macaque MAPK13/SAPK4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10372-Ag-1/ GM-Tg-felg-IP10372-Ag-2 Feline MAPK13/SAPK4 protein Feline
GM-Tg-cang-IP10372-Ag-1/ GM-Tg-cang-IP10372-Ag-2 Canine MAPK13/SAPK4 protein Canine
GM-Tg-bovg-IP10372-Ag-1/ GM-Tg-bovg-IP10372-Ag-2 Bovine MAPK13/SAPK4 protein Bovine
GM-Tg-equg-IP10372-Ag-1/ GM-Tg-equg-IP10372-Ag-2 Equine MAPK13/SAPK4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10372-Ag-1/ GM-Tg-hg-IP10372-Ag-2; GM-Tg-rg-IP10372-Ag-1/ GM-Tg-rg-IP10372-Ag-2;
GM-Tg-mg-IP10372-Ag-1/ GM-Tg-mg-IP10372-Ag-2; GM-Tg-cynog-IP10372-Ag-1/ GM-Tg-cynog-IP10372-Ag-2;
GM-Tg-felg-IP10372-Ag-1/ GM-Tg-felg-IP10372-Ag-2; GM-Tg-cang-IP10372-Ag-1/ GM-Tg-cang-IP10372-Ag-2;
GM-Tg-bovg-IP10372-Ag-1/ GM-Tg-bovg-IP10372-Ag-2; GM-Tg-equg-IP10372-Ag-1/ GM-Tg-equg-IP10372-Ag-2
Products Name MAPK13/SAPK4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MAPK13/SAPK4
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAPK13/SAPK4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.